We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cabot Corporation‘s (CBT - Free Report) shares reached a fresh 52-week high of $110.98 on Sept. 18 before closing at $107.85.
CBT’s stock has appreciated 55.8% in the past year against the industry’s 4.3% fall.
Image Source: Zacks Investment Research
What’s Driving Cabot?
In the fiscal third quarter, Cabot's Performance Chemicals division posted robust growth, with sales climbing 8.1% year over year to $332 million. The segment’s EBIT surged 72% to $55 million, driven by higher volumes and a favorable product mix, particularly in specialized carbons and fumed metal oxides. The upside was fueled by strong automotive, infrastructure and semiconductor market demand.
The Reinforcement Materials segment also registered gains, benefiting from increased volumes in Europe and Asia Pacific and better pricing and product mix in 2024 customer agreements.
CBT is optimistic about its fiscal fourth-quarter outlook. CBT raised its fiscal 2024 adjusted EPS guidance to $7.00-$7.10, suggesting a 30-cent increase at the midpoint. The upward revision reflects anticipated strong results from the Performance Chemicals division and ongoing strength in the Reinforcement Materials segment.
The company’s earnings have consistently surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the earnings surprise being 8.6%, on average. The Zacks Consensus Estimate for fiscal 2024 earnings is pegged at $7.07, indicating a 31.4% year-over-year increase. Earnings are expected to move up 10.6% in the fiscal 2025. In the past two months, the Zacks Consensus Estimate for Cabot’s fiscal 2024 earnings has been revised upward by 4.3%.
The Zacks Consensus Estimate for IAMGOLD’scurrent-year earnings is pegged at 41 cents per share, indicating a rise of 355.6% from the year-ago level. IAG’s earnings beat the consensus estimate in each of the trailing four quarters, with the average surprise being 200%. The stock has surged nearly 114.2% in the past year.
The Zacks Consensus Estimate for Eldorado Gold’s current year earnings is pegged at $1.35 per share, indicating a year-over-year rise of 136.8%. EGO beat the consensus estimate in each of the trailing four quarters, with the average earnings surprise being 430.3%. The company's shares have surged nearly 70.6% in the past year.
The Zacks Consensus Estimate for Hawkins’ current fiscal-year earnings is pegged at $4.14 per share, indicating a rise of 15.3% from the year-ago level. The Zacks Consensus Estimate for HWKN’s current fiscal-year earnings has increased 12.8% in the past 60 days.The stock has appreciated around 101.7% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cabot's Shares Reach Fresh 52-Week High: What's Driving It?
Cabot Corporation‘s (CBT - Free Report) shares reached a fresh 52-week high of $110.98 on Sept. 18 before closing at $107.85.
CBT’s stock has appreciated 55.8% in the past year against the industry’s 4.3% fall.
Image Source: Zacks Investment Research
What’s Driving Cabot?
In the fiscal third quarter, Cabot's Performance Chemicals division posted robust growth, with sales climbing 8.1% year over year to $332 million. The segment’s EBIT surged 72% to $55 million, driven by higher volumes and a favorable product mix, particularly in specialized carbons and fumed metal oxides. The upside was fueled by strong automotive, infrastructure and semiconductor market demand.
The Reinforcement Materials segment also registered gains, benefiting from increased volumes in Europe and Asia Pacific and better pricing and product mix in 2024 customer agreements.
CBT is optimistic about its fiscal fourth-quarter outlook. CBT raised its fiscal 2024 adjusted EPS guidance to $7.00-$7.10, suggesting a 30-cent increase at the midpoint. The upward revision reflects anticipated strong results from the Performance Chemicals division and ongoing strength in the Reinforcement Materials segment.
The company’s earnings have consistently surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the earnings surprise being 8.6%, on average. The Zacks Consensus Estimate for fiscal 2024 earnings is pegged at $7.07, indicating a 31.4% year-over-year increase. Earnings are expected to move up 10.6% in the fiscal 2025. In the past two months, the Zacks Consensus Estimate for Cabot’s fiscal 2024 earnings has been revised upward by 4.3%.
Cabot Corporation Price and Consensus
Cabot Corporation price-consensus-chart | Cabot Corporation Quote
CBT’s Zacks Rank & Other Key Picks
Cabot currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the Basic Materials space are IAMGOLD Corporation (IAG - Free Report) , Eldorado Gold Corporation (EGO - Free Report) and Hawkins, Inc. (HWKN - Free Report) . While IAMGOLD and Eldorado Gold sport a Zacks Rank #1 (Strong Buy), Hawkins carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for IAMGOLD’scurrent-year earnings is pegged at 41 cents per share, indicating a rise of 355.6% from the year-ago level. IAG’s earnings beat the consensus estimate in each of the trailing four quarters, with the average surprise being 200%. The stock has surged nearly 114.2% in the past year.
The Zacks Consensus Estimate for Eldorado Gold’s current year earnings is pegged at $1.35 per share, indicating a year-over-year rise of 136.8%. EGO beat the consensus estimate in each of the trailing four quarters, with the average earnings surprise being 430.3%. The company's shares have surged nearly 70.6% in the past year.
The Zacks Consensus Estimate for Hawkins’ current fiscal-year earnings is pegged at $4.14 per share, indicating a rise of 15.3% from the year-ago level. The Zacks Consensus Estimate for HWKN’s current fiscal-year earnings has increased 12.8% in the past 60 days.The stock has appreciated around 101.7% in the past year.